BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 19930013)

  • 1. Persistence of heroin use despite methadone treatment: poor coping self-efficacy predicts continued heroin use.
    Senbanjo R; Wolff K; Marshall EJ; Strang J
    Drug Alcohol Rev; 2009 Nov; 28(6):608-15. PubMed ID: 19930013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing drug-related hospital morbidity following heroin dependence treatment with methadone maintenance or naltrexone implantation.
    Ngo HT; Tait RJ; Hulse GK
    Arch Gen Psychiatry; 2008 Apr; 65(4):457-65. PubMed ID: 18391134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excessive alcohol consumption is associated with reduced quality of life among methadone patients.
    Senbanjo R; Wolff K; Marshall J
    Addiction; 2007 Feb; 102(2):257-63. PubMed ID: 17222280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ; Maynard C; Koepsell TD; Wells EA; Donovan DM
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a single 50% extra dose of methadone on heroin craving and mood in lower- versus higher-dose methadone patients.
    Strasser J; Wiesbeck GA; Meier N; Stohler R; Dürsteler-Macfarland KM
    J Clin Psychopharmacol; 2010 Aug; 30(4):450-4. PubMed ID: 20571436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized controlled trial of interim methadone maintenance.
    Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
    Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts.
    Fareed A; Casarella J; Amar R; Vayalapalli S; Drexler K
    J Psychiatr Pract; 2009 May; 15(3):227-34. PubMed ID: 19461397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trial of prescribed heroin in the treatment of opioid addiction.
    March JC; Oviedo-Joekes E; Perea-Milla E; Carrasco F;
    J Subst Abuse Treat; 2006 Sep; 31(2):203-11. PubMed ID: 16919749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 'Topping up' methadone: an analysis of patterns of heroin use among a treatment sample of Scottish drug users.
    Bloor M; McIntosh J; McKeganey N; Robertson M
    Public Health; 2008 Oct; 122(10):1013-9. PubMed ID: 18490036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
    Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
    Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors associated with continued heroin use during methadone maintenance treatment in Guizhou province, China].
    Liu EW; Wu ZY; Liang T; Shen LM; Zhong H; Wang B; Roger D
    Zhonghua Yu Fang Yi Xue Za Zhi; 2008 Dec; 42(12):875-8. PubMed ID: 19141219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple substance use among heroin-dependent patients before and during attendance at methadone maintenance treatment program, Yunnan, China.
    Li L; Sangthong R; Chongsuvivatwong V; McNeil E; Li J
    Drug Alcohol Depend; 2011 Jul; 116(1-3):246-9. PubMed ID: 21282020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved quality of life, clinical, and psychosocial outcomes among heroin-dependent patients on ambulatory buprenorphine maintenance.
    Ponizovsky AM; Margolis A; Heled L; Rosca P; Radomislensky I; Grinshpoon A
    Subst Use Misuse; 2010; 45(1-2):288-313. PubMed ID: 20025454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of symptom complaints in methadone maintenance patients.
    Dyer KR; White JM
    Addiction; 1997 Nov; 92(11):1445-55. PubMed ID: 9519488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors which were associated with heroin use during the methadone maintenance treatment among 1301 patients in 9 cities of China.].
    Cao XB; Yin WY; Pang L; Zhang CB; Xu JS; Xiao YK; Wang CH; Luo W; Zhang B; Zhang RM; Li ZJ; Rou KM; Wu ZY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Mar; 31(3):269-72. PubMed ID: 20510050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.